A clinical trial has led to the approval of a treatment for patients with a rare, muscle-weakening disease called GNE myopathy.
Aceneuramic acid is the first approved drug for GNE myopathy treatment
- Post author:
- Post published:August 20, 2024
- Post category:News Feed
- Post comments:0 Comments